Frank Karbe Phathom Pharmaceuticals, Inc. (PHAT) insider trading activity

PHAT Quotes by TradingView

Frank Karbe is of Phathom Pharmaceuticals, Inc.. Currently has a direct ownership of 44,500 shares of PHAT, which is worth approximately $804,559. The most recent transaction as insider was on May 29, 2024, when has been sold 25,000 shares (Common Stock) at a price of $10.16 per share, resulting in proceeds of $254,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.5K
0% 3M change
394.44% 12M change
Total Value Held $804,559

FRANK KARBE Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2024
BUY
Grant, award, or other acquisition
$254,000 $10.16 p/Share
25,000 Added 35.97%
44,500 Common Stock
May 23 2024
BUY
Grant, award, or other acquisition
-
10,500 Added 35.0%
19,500 Common Stock
May 25 2023
BUY
Grant, award, or other acquisition
-
9,000 Added 50.0%
9,000 Common Stock

Also insider at

MYOV
Myovant Sciences Ltd. Healthcare
Principal Fin'l & Accounting
BTTX
Better Therapeutics, Inc. Healthcare
Chief Executive Officer
FK

Frank Karbe

San Francisco, CA

Track Institutional and Insider Activities on PHAT

Follow Phathom Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHAT shares.

Notify only if

Insider Trading

Get notified when an Phathom Pharmaceuticals, Inc. insider buys or sells PHAT shares.

Notify only if

News

Receive news related to Phathom Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHAT